61-Year-Old Pharmaceutical Distributor For Sale In Mumbai

About Business

The company is a long-established and reputable authorized stockist representing over 80 well-known pharmaceutical, nutraceutical, Ayurvedic, OTC, FMCG, and F&B brands across both domestic and international markets. With more than 60 years of industry presence, it operates as a debt-free, family-owned business recognized for its ethical practices, transparency, and consistent 15% year-on-year growth over the past three years.

The business has implemented tech-driven operations, including a mobile app-based ordering system and a custom ERP tailored to its distribution workflow, covering end-to-end processes including accounting.
It holds authorized stockist status for all of India's top 5 pharmaceutical companies and 7 of the top 10, meeting their rigorous compliance and due diligence standards - a testament to the company’s credibility and operational excellence.

Exclusive Business Verticals:

1. Pan India Monopoly - Spanish Healthcare Brand
The company is the exclusive importer and distributor for a Spanish healthcare brand in India. With high-margin products and a strong edge in marketing, this business vertical operates across major e-commerce platforms such as Amazon India, Flipkart, and 1mg. The products have little to no direct competition and are entirely managed in-house, including imports and nationwide distribution through state-level channel partners.

2. Specialized Anti-Aging Product Distribution
The company also serves as an authorized distributor for a global anti-aging healthcare brand, supplying premium products like BOTOX exclusively to certified healthcare professionals in the cosmetic dermatology space. This vertical benefits from a high entry barrier, offering a niche and defensible position within a high-value segment.

F&B Business Opportunity The company also operates as a distributor for a reputed coffee brand in India, handling a client base assigned directly by the brand. This vertical caters to high-end clientele, including 5-star hotels, cinema chains, corporate offices, and automobile showrooms. Despite being a secondary focus, this segment yields significantly higher margins than the core pharmaceutical business and presents strong growth potential in the expanding F&B sector.

Clientele type

They supply to pharmacies, hospitals, clinics, and doctors.

Premises

OWNED

Premise Size: 1700 SQ FT

Market Value (in INR): 1.00 L

The premises are owned but are not included in the deal.

Asking Price Includes

The asking price covers the intellectual property, goodwill, and full business rights. It does not include ownership of the property or physical assets.

Reason

The current owner intends to exit the business due to retirement.

Licenses

Documentation: They have written agreements with most of their Principals. All the necessary FDA, FSSAI, MCGM, GST, etc. documentation is in valid condition.

More Details

Experienced Workforce:
The company is supported by a team of highly experienced staff, with an average tenure of 15 to 20 years. This well-trained workforce ensures smooth day-one operations for any incoming stakeholder or investor, offering operational continuity and domain expertise.


Zero Loss on Dead Stock:
In the branded generics space, the risk of dead stock, expiry, or product damage is mitigated by pharmaceutical companies offering full buyback or credit notes. This industry practice ensures stockists face minimal financial risk and maintain capital safety.

No Marketing Overheads:
Product marketing is managed by the respective pharmaceutical companies through their dedicated medical representative teams. As a result, the business benefits from strong product demand without incurring additional marketing expenses.

Revenue Distribution:
80% from pharmaceutical distribution
15% from nutraceutical, OTC, and FMCG products
5% from the F&B distribution business